it would be a gamble if someone was to try take over the company now, cant see it happening.
good potential, but why take the risk
Vaccine - uncertain
Cardiocel - proven product, but hasn't proven to be market disruptive (maybe as time goes by)
Vascucel - same as Cardiocel.
They tidied up a few loose ends in the last quarter, staffing and regen ownership, that's a plus.
Got the manufacturing process up to scratch.
The above came at a cost, underlying it is good but the last Q still saw $6.8m out the door.
need to show that these 1 off's aren't a recurring. feature for AHZ
So nothing to excite a potential takeover or the share price.
Could be a boring quarter with sp drifting back unless they get some good numbers news. A new pump contract or lightning initial Vascucel sales announcement might do it.
Same old same old for AHZ, always waiting for next Q.
- Forums
- ASX - By Stock
- AVR
- Possible take over
Possible take over, page-36
-
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
|
|||||
Last
$15.25 |
Change
-0.250(1.61%) |
Mkt cap ! $322.3M |
Open | High | Low | Value | Volume |
$15.50 | $15.50 | $14.80 | $140.4K | 9.315K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 297 | $15.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.25 | 1300 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 60 | 14.800 |
1 | 206 | 14.500 |
1 | 1388 | 14.400 |
1 | 60 | 14.350 |
1 | 38 | 14.260 |
Price($) | Vol. | No. |
---|---|---|
15.250 | 1300 | 2 |
15.400 | 238 | 1 |
15.500 | 370 | 1 |
15.660 | 1925 | 2 |
15.950 | 848 | 2 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
AVR (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online